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DObjective: The objective of this study was to evaluate the efficacy of a novel approach for endocardectomy dur-
ing coronary artery bypass graft with surgical ventricular restoration in patients with postinfarction left ventric-
ular aneurysm.
Methods: One hundred sixty-eight patients underwent coronary artery bypass graft with surgical ventricular
restoration from 2005 to 2011. Endocardectomy was performed as an integral part of surgical ventricular
restoration for the prevention of ventricular tachycardia. The experimental group (surgical ventricular restora-
tion–endocardectomy group; n¼ 74) underwent preoperative electrophysiologic study with electroanatomic left
ventricular mapping. Radiofrequency ablation-induced markings were placed and were used later as guides for
performing endocardectomy during coronary artery bypass graft with surgical ventricular restoration. The con-
trol group (surgical ventricular restoration group; n ¼ 94) underwent surgical ventricular restoration without
endocardectomy.
Results: The 1-year mortality rates in the surgical ventricular restoration–endocardectomy and surgical ventric-
ular restoration (control) groups were 5% and 13%, respectively. During the postoperative period, 3% of pa-
tients in the surgical ventricular restoration–endocardectomy group and 38% of patients in the surgical
ventricular restoration group experienced ventricular tachycardia events (P<.05). Automatic implantable car-
dioverter–defibrillators were implanted in 11 patients in the surgical ventricular restoration group and in 1 patient
of the surgical ventricular restoration–endocardectomy group for secondary prevention of sudden cardiac death.
Conclusions: When performed as an integral part of surgical ventricular restoration, endocardectomy was
crucial in preventing postoperative ventricular tachycardia. Use of radiofrequency ablation-induced markings
allowed clear visualization of the reentry zones for efficient endocardectomy during coronary artery bypass graft
with surgical ventricular restoration, resulting in better patient outcomes. (J Thorac Cardiovasc Surg
2013;146:1133-8)Video clip is available online.
Development of postinfarction left ventricular aneurysm
(LVA) significantly worsens the prognosis of coronary ar-
tery disease resulting from life-threatening complications.
The 5-year survival rate in patients with untreated postin-
farction aneurysms ranges between 25% and 60%. Ventric-
ular arrhythmia is the cause of mortality in 50% of patients
with postinfarction left ventricular (LV) remodeling.1-3 The
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The Journal of Thoracic and Carshowed that implantation of an automatic implantable
cardioverter–defibrillator (AICD)4 was life-saving for pa-
tients with severe LV dysfunction.
Surgery improves the prognosis and clinical course for
patients with heart aneurysms.5-8 The Surgical Treatment
for Ischemic Heart Failure Trial reported similar mortality
rates in patients subjected to coronary artery bypass
grafting (CABG) with or without surgical ventricular
reconstruction (SVR).9 These findings suggest the safety
of an extra LV surgery, such as SVR, in addition to
CABG in patients with coronary artery disease, LV
dysfunction, and heart failure. The Surgical Treatment for
Ischemic Heart Failure Trial investigators did not study as-
sociations between mortality and ventricular dysrhythmias.
However, evidence suggests that a subendocardial scar
burden may be a predictor of subsequent arrhythmogenic-
ity.10 Many research teams have shown the efficacy of
aneurysmectomy with endocardial resection in the treat-
ment of ventricular tachycardia (VT).11-15
The objective of the study was to evaluate the clinical ef-
ficacy of a new approach for endocardectomy (EE) during
CABG/SVR in patients with postinfarction LVA. EE duringdiovascular Surgery c Volume 146, Number 5 1133
Abbreviations and Acronyms
AICD ¼ automatic implantable cardioverter–
defibrillator
CABG ¼ coronary artery bypass grafting
EE ¼ endocardectomy
EPS ¼ electrophysiologic study
LV ¼ left ventricular
LVA ¼ left ventricular aneurysm
RFA-M ¼ radiofrequency ablation-induced marking
SVR ¼ surgical ventricular reconstruction
VT ¼ ventricular tachycardia
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DSVR was guided by radiofrequency ablation-induced mark-
ings (RFA-Ms), placed during a preoperative intracardiac
electrophysiologic study (EPS) with electroanatomic map-
ping of the left ventricle.METHODS
From January 2005 to December 2011, 5091 cardiopulmonary bypass
surgeries were performed at the authors’ institute, including 2318 surgeries
for coronary artery disease. Of these, 264 of the operated patients had
ischemic cardiomyopathy and LVA. Patients with postinfarction anterosep-
tal LVAwith LV remodeling types I, II, and III16 were included in the study
(n ¼ 168). Patients with posterior LVAwere excluded from the study. Pre-
operatively, most patients enrolled in the study were diagnosed with angina
of Canadian Cardiovascular Society class III or IVand heart failure of New
York Heart Association class II or III (Table 1). According to ventriculog-
raphy and echocardiography, all patients had signs of postinfarction LV
remodeling.
From May 2007, EPS with electroanatomic mapping of the left
ventricle17 was included in the preoperative examination of patients for
identification of delayed conduction areas, reentry zones, and VT induc-
ibility (Figure 1, Video 1). The identified arrhythmogenic zones were
marked with RFA-Ms by using an ablation electrode with a radiofrequency
power of 45Wand saline irrigation at 17mL/min. TheRFA-Mswere placed
on the borders of pathologic zones for their further resection during open
surgery and remained visible for up to 10 days after application. The exclu-
sion criteria for performing EPS were thrombus in the LV cavity; aortic,
iliac, and femoral arterial occlusion and stenosis; and refusal by the patient
to participate in the study.
The SVR procedures were performed using the standard methods devel-
oped by Dor and colleagues6 or Menicanti and associates8 with or without
EE.11-15 One hundred thirty patients underwent aneurysm resection and
LV reconstruction using the method by Dor and colleagues,6 whereas 38 pa-
tients underwent SVR as done byMenicanti and associates.8 Repair ofmitral
valve insufficiency with a mitral annuloplasty ring was performed in 26
patients from both groups. All 168 patients underwent CABG surgery.
All 168 patients were allocated retrospectively to 2 groups. The main
group (n ¼ 74) included patients subjected to SVR with EE (SVR/EE
group). The control group consisted of 94 patients who underwent SVR
without endocardial resection (SVR group). Preoperative cardiac magnetic
resonance imaging of the diastolic phase in a synchronizing mode showed
infarcted myocardium perimeters of 55.5% 5.3% and 49.8% 6.7% of
the total LV perimeter in the SVR/EE and control SVR group, respectively.
According to preoperativeHolter monitoring, 43% of the patients undergo-
ing SVR/EE and 49% of the control SVR patients had ventricular extra sys-
toles. Data from the clinical and instrumental examinations did not reveal
significant differences between the groups before treatment.1134 The Journal of Thoracic and Cardiovascular SurNot all patients from the main and control groups underwent both pre-
operative and postoperative EPS procedures with LVelectroanatomic map-
ping. Some patients had contradictions, whereas others refused to undergo
EPS examination. Patients from the SVR/EE and control SVR groups who
underwent both preoperative and postoperative EPS were assigned retro-
spectively to subgroups A (n ¼ 38) and B (n ¼ 32), respectively.
Four surgeons operated on patients from the control SVR group starting
in January 2005. InMay 2007, 2 of the 4 surgeons, after being trained in the
EE procedure, started to perform SVR/EE (n ¼ 74). No significant differ-
ences in the outcomes of the CABG/SVR procedureswere found in patients
operated on by different surgeons. The FF technique consists of isolating
and resecting the septal, apical, and anterior LV walls and endocardial scar
tissue according to RFA-Ms applied to the scarred area 4 to 5 mm from the
border between the scar and vital myocardium. The average area of re-
sected endocardium was 48 cm2 (range, 18-83 cm2).
The postoperative antithrombotic protocol in uncomplicated patients
did not differ between the groups and included low-molecular weight hep-
arin for 3 days after the operation, acetylsalicylic acid 75 mg/day, and/or
clopidogrel 75 mg/day. Patients with atrial fibrillation and/or mitral valve
repair received warfarin therapy with anticoagulation control (international
normalized ratio, 2.0-3.0).
Statistical analyses were done with SSPS 11.5 for Windows. Distribu-
tions of the quantitative variables were evaluated for normality by the
Shapiro-Wilk test. Normally distributed data were described with the
mean and standard deviation. Qualitative data were described with the
occurrence rate or percentage. To evaluate the significance of differences
between quantitative values in the compared groups, Student t test was
applied after confirmation of normal distribution. The Z criterion (Fisher
exact test) was used to determine whether there were nonrandom associa-
tions between the categorical variables. The significance of differences
in postoperative mortality was evaluated using the Kaplan-Meier method.
Values were considered statistically significant when P was < .05.
The study was approved by the local ethics committee of the authors’
institute.RESULTS
Survival
The overall in-hospital mortality for patients who under-
went SVR was 4% (7/168 patients). The mortality rates
were 1% (1/74 patients) for the SVR/EE group and 6%
(6/94 patients) for the control SVR group. One patient
from the SVR/EE group died from low cardiac output syn-
drome on postoperative day 12. In the control group, 3 pa-
tients were diagnosed with perioperative myocardial
infarction and progressive heart failure, 2 died from low car-
diac output syndrome, and 1 patient died from stroke.
One-year survival rates were 95% (70/74 patients) in the
SVR/EE group and 87% (82/94 patients) in the control
SVR group (P<.05). Causes of postoperative mortality in
the SVR/EE group were progressive heart failure, acute
myocardial infarction, and noncardiac reason (1 patient).
Causes for postoperative mortality in the control group
were progressive heart failure (2 patients), stroke (1 pa-
tient), and sudden cardiac death resulting from to VTor ven-
tricular fibrillation (3 patients).Cardiac Function
Progressive improvement in LV function was confirmed
by echocardiography 1 month after surgery. The LVgery c November 2013
TABLE 1. Preoperative clinical characteristics of the patients
Patient characteristics*
SVR/EE
(main group,
n ¼ 74)
SVR
(control group,
n ¼ 94)
Median age, y (interquartile range) 54 (50-60) 56 (52-62)
Female sex, n (%) 6 (8) 7 (7)
No. of previous MIs, mean  SD 1.4  0.5 1.3  0.5
Time from previous MI, y, mean  SD 3.7  0.9 3.9  1.2
Current CCS angina class, n (%)
Class II 7 (9) 9 (10)
Class III 27 (36) 34 (36)
Class IV 26 (35) 34 (36)
Unstable angina 14 (19) 17 (18)
Current NYHA heart failure class, n (%)
Class I 1 (1) 3 (3)
Class II 15 (20) 21 (22)
Class III 52 (70) 65 (69)
Class IV 6 (8) 5 (5)
Type of LVA, n (%)
1 41 (55) 55 (58)
2 26 (35) 32 (34)
3 7 (9) 7 (7)
Ventricular tachycardia, n (%)
Spontaneous 11 (15) 12 (13)
Induced 26 (35) 28 (30)
Ventricular extrasystoles, n (%) 32 (43) 46 (49)
Mitral regurgitation 2þ, fibrous
ring>35 mm, n (%)
13 (18) 13 (14)
Coronary artery lesions, n (%)
1 24 (32) 33 (35)
2 25 (34) 33 (35)
3 25 (34) 28 (30)
Diabetes mellitus, n (%) 19 (26) 23 (24)
Hypertension, n (%) 47 (64) 63 (67)
Values are mean  standard deviation. SVR, Surgical ventricular reconstruction; EE,
endocardectomy; MI, myocardial infarction; SD, standard deviation; CCS, Canadian
Cardiovascular Society; NYHA, New York Heart Association; LVA, left ventricular
aneurysm. *P>.05 for all between-group comparisons.
FIGURE 1. Preoperative electrophysiologic study and electroanatomic
left ventricular mapping showing the zones of electrical silence (scar tis-
sue; gray), zones of low-amplitude ventricular capacity of about 0.5 mV
(red), transient zones from 0.5 to 1.5 mV (yellow-green-blue), vital
myocardium zones (violet), double capacity (blue dots), delayed conduc-
tion zones (pink dots), radiofrequency ablation-induced markings on the
borders between pathologic zones and vital myocardium (maroon dots).
R, Right side; AP, anterior-posterior projection (anterior view).
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Dejection fraction increased from 39% before surgery to
48% after surgery (P< .01) in the SVR/EE group and
from 40% to 51% (P< .01) in the control SVR group.
The mean LV end-diastolic volume index decreased from
116 mL/m2 to 80 mL/m2 (P< .01) in the SVR/EE group
and from 111 mL/m2 to 79 mL/m2 (P<.01) in the control
group. The LV end-systolic volume index decreased from
74 mL/m2 to 49 mL/m2 (P<.01) and from 68 mL/m2 to
47 mL/m2 (P< .01) in the SVR/EE and control groups,
respectively. No statistically significant differences were
found between the hemodynamic values in the groups.EPS With LV Electroanatomic Mapping
Asmentioned, patients from the SVR/EE and control SVR
groups who underwent both preoperative and postoperative
EPSwithLVelectroanatomicmappingwere divided into sub-
groups A (n ¼ 38) and B (n ¼ 32), respectively. We foundThe Journal of Thoracic and Carimprovement in the EPS parameters after SVR/EE in all
patients of subgroup A. Electrical scar zones were identified
only in the areas of endoventricular patches, low-conduction
areas disappeared completely, and transient zones (0.5-1.5
mV) comprised a limited area with unlikely reentry occur-
rence and VT induction (Figure 2, Video 2). In subgroup
A, monomorphic VT was induced in only 1 patient, who
had incomplete endocardectomy (Table 2). No spontaneous
VT episodes occurred in this subgroup postoperatively.
According to Holter monitoring data, spontaneous VT
episodes were documented in 5 patients in subgroup B,
and VT was induced during EPS in 7 patients in this sub-
group within the first postoperative year (Figure 3, Video
3). Spontaneous and induced VTevents affected 38% of pa-
tients (12/32) from subgroup B.
For secondary prevention of sudden cardiac death,
AICDs were implanted in 11 patients (34%) of subgroup
B and 1 patient (3%) of subgroup A (Table 3).diovascular Surgery c Volume 146, Number 5 1135
FIGURE 2. Electrophysiologic study and electroanatomic left ventricular
mapping after surgical ventricular reconstruction with endocardectomy (40
cm2) of the entire apex, half of the ventricular septum, and the anterior left
ventricular wall. Electrical scar was found in an area of the endoventricular
patch only (gray). The transient zone (yellow-green-blue) was found in a
limited area with an unlikely occurrence of reentry and ventricular tachy-
cardia induction. Yellow dots show His bundle and left bundle branch.
R, Right side; AP, anterior-posterior projection (anterior view).
FIGURE 3. Electrophysiologic study and electroanatomic left ventricular
mapping after surgical ventricular reconstruction without endocardectomy;
coronary artery bypass graft surgerywas performed.Noted are large zones of
low-amplitude ventricular capacity (red) and transient zones (yellow-green-
blue) with delayed conduction zones (pink dots).Ventricular tachycardiawas
registered during the postoperative period. A cardioverter–defibrillator was
implanted in this patient. R, Right side; AP, anterior-posterior projection
(anterior view); LAO, left anterior oblique view.
TABLE 3. Outcomes and subsequent procedures
Variable, n (%)
SVR/EE
(subgroup A,
n ¼ 38)
SVR
(subgroup B,
n ¼ 32)
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DDISCUSSION
Infarcted LV myocardium may cause fatal ventricular
arrhythmias.1-4,18 Recent studies have shown that the
myocardial zone surrounding LVA scar tissue is a source
of monomorphic and polymorphic premature ventricular
contractions.19 The larger the postinfarction area according
to magnetic resonance imaging, the greater the risk of
developing VT.10 Endocardial mapping provides valuable
information on the presence and localization of LV excita-
tion sites and facilitates further surgical treatment.3,6,18
The transient zone between scar tissue and vital myocar-
dium, with potentials ranging from 0.5 to 1.5 mV, isTABLE 2. Ventricular tachycardia in patients before and after
surgery
Variable
SVR/EE
(subgroup A, n ¼ 38)
SVR
(subgroup B, n ¼ 32)
Spontaneous Induced Spontaneous Induced
Before surgery, n (%) 6 (16) 15 (39) 6 (19) 12 (38)
After surgery, n (%) 0* 1 (3)* 5 (16)y 7 (22)y
SVR, Surgical ventricular reconstruction; EE, endocardectomy. *P < .05 within
groups. yP<.05 between groups.
1136 The Journal of Thoracic and Cardiovascular Surof special interest. Both double potential and delayed
conduction are usually found in this zone, and this potential
may cause reentry and VT. We used RFA to markOutcome
Acute myocardial infarction 1 (3) 2 (6)
Stroke 0 2 (6)
Low cardiac output syndrome 2 (6) 2 (6)
Renal failure 1 (3) 0
Death from any cause within 1 year
after surgery
1 (3) 3 (9)
Subsequent procedure
Coronary artery bypass graft 1 (3) 0
AICD placement 1 (3) 11 (34)*
SVR, Surgical ventricular reconstruction; EE, endocardectomy; AICD, automatic
implantable cardioverter–defibrillator. *P<.05 between groups.
gery c November 2013
Babokin et al Acquired Cardiovascular Disease
A
C
Dpathologic zones found during EPS. The RFA-Ms appeared
as yellow-brown spots with clear edges and a size of about 4
to 5 mm. According to intraoperative data, the RFA-Ms re-
mained visible for approximately 10 days after application.
Clear visualization of the affected endocardium, including
transient zones with reentry sources, enabled optimal resec-
tion of the endocardium within the verified edges.
Although not all surgeons perform SVR to treat LV sys-
tolic dysfunction,9 SVR with EE may prevent the develop-
ment of fatal ventricular rhythm disturbances.11,13,15
Known surgical approaches in the treatment of patients
with postinfarction LVA include partial isolation of
affected endocardial areas from the LV cavity, often
without their complete resection, which leaves VT
sources in the heart and may necessitate further AICD
implantation.9,12 The use of RFA-Ms during EPS guided
the endocardial resection process, allowing us to remove
only the abnormal tissue without altering the vital tissue.
This process prevented complications, such as low cardiac
output resulting from excessive myocardial resection and
VT resulting from to insufficient EE. The single postoper-
ative case of VT induction in a patient with incomplete
resection of abnormal endocardium (subgroup A) demon-
strated the importance of performing the EE procedure
correctly. To our knowledge, no available study in the
literature describes identical or similar approaches to VT
treatment in patients with postinfarction changes in the
heart.
The results of postoperative EPS with electroanatomic
LV mapping in the SVR group without EE showed that
the sources of reentry and VT found preoperatively per-
sisted after SVR, which posed a high patient health risk
(Figure 3, Video 3). Twelve patients (38%) in the SVR
group without EE had indications for AICD placement as
a secondary prevention of sudden cardiac death after sur-
gery (Table 2; ie, VT episodes were registered postopera-
tively). However, most patients who underwent SVR/EE
did not have such indications. No significant differences
were observed in the rates of postoperative complications
between the groups, and no strokes were observed in sub-
group A (Table 3). These results suggest that SVR/EE did
not increase the risks compared with SVR without EE.
The observed low mortality rate and very low rate of indi-
cations for AICD placement confirmed the superiority of
SVR/EE over SVR without EE.
Limitations
We did not perform both preoperative and postoperative
EPS in some patients because of contraindications, tech-
nical reasons, or refusal by the patient to undergo the exam-
ination. Although this study represents a large EPS series in
patients with postinfarction LVA, the data acquired during
the 5-year postoperative follow-up period have not yet
been analyzed. Decisions regarding the preferred surgicalThe Journal of Thoracic and Carapproach (SVR/EE or SVR alone) for patients were made
by our 4 surgeons according to their preference. Despite
the comparable number of different aneurysm types in the
main and control groups, we did not compare the subgroups
with the same LVA types.CONCLUSIONS
Our data suggest that endocardial resection of scarred
and transient LV areas is a crucial aspect in the surgical
treatment of postinfarction heart aneurysms because it pre-
vents postoperative VT episodes. Endocardial EPS and
electroanatomic LV mapping allow the identification of
zones with likely reentry occurrence. When placed during
endocardial EPS, RFA-Ms may aid in the precise identifica-
tion of the area of a lesion during open surgery for the
optimal performance of EE.References
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